Market Shifts Ahead

Catalan's syringe production is booked through 2026, driven by soaring demand for Ozempic, while the PGA Tour offers equity to players to strengthen alignment with commercial success. Inflation is falling, which could signal a return to lower interest rates, greatly impacting growth stocks. In a surprising turn, OpenAI's board ousts its CEO, citing a lack of transparency, and appoints the CTO as interim leader.